Skip to main content
ICU
NASDAQ Life Sciences

SeaStar Medical Q2 Revenue Jumps 82% as Pediatric AKI Device Gains Traction

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$3.36
Mkt Cap
$13.43M
52W Low
$2.07
52W High
$12.5
52W Position info
62% above low
Off High info
73% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

ICU sits 62% above its 52-week low of $2.07.

Summary

SeaStar Medical reported Q2 2026 net revenue of $0.6M, up 82% year-over-year, driven by three new top-rated children's hospital customers for its QUELIMMUNE pediatric AKI device. Gross margins held at 91%. The company also advanced its NEUTRALIZE-AKI pivotal trial to 223 of 339 enrolled adult patients, with enrollment completion expected around year-end or early 2027. New ICD-10-PCS billing codes take effect October 1, 2026, which should streamline hospital reimbursement. The company remains in a going-concern situation with less than 12 months of cash, so the revenue growth and trial progress are critical to its survival.

Updates

  1. · SEC 10-Q — Cash fell to $7.0M at June 30, 2026 from $12.0M at year-end 2025; net loss was $7.3M for H1 2026.

At the time of this announcement, ICU was trading at $3.36 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $13.4M. The 52-week trading range was $2.07 to $12.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

ICU - Latest Insights

ICU
Nov 12, 2026, 8:15 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.67
Real-time Price: $0.9949 info
Change: -$0.6751 (-40%) info
Market Cap: $5.529M info
ICU
Nov 12, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.67
Real-time Price: $0.9949 info
Change: -$0.6751 (-40%) info
Market Cap: $5.529M info
ICU
Nov 11, 2026, 4:06 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.92
Real-time Price: $0.9949 info
Change: -$0.9251 (-48%) info
Market Cap: $5.529M info
ICU
Nov 03, 2026, 8:21 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.40
Real-time Price: $0.9949 info
Change: -$1.41 (-59%) info
Market Cap: $5.529M info
ICU
Oct 22, 2026, 12:01 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.22
Real-time Price: $0.9949 info
Change: -$2.23 (-69%) info
Market Cap: $5.529M info